- Home
- PRAX vs GES Comparison
PRAX vs GES Comparison
Compare PRAX & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- GES
- Stock Information
- Founded
- PRAX 2015
- GES 1981
- Country
- PRAX United States
- GES Switzerland
- Employees
- PRAX N/A
- GES N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- PRAX Health Care
- GES Consumer Discretionary
- Exchange
- PRAX Nasdaq
- GES Nasdaq
- Market Cap
- PRAX 599.7M
- GES 547.7M
- IPO Year
- PRAX 2020
- GES 1996
- Fundamental
- Price
- PRAX $46.32
- GES $12.94
- Analyst Decision
- PRAX Strong Buy
- GES Buy
- Analyst Count
- PRAX 11
- GES 4
- Target Price
- PRAX $114.73
- GES $17.75
- AVG Volume (30 Days)
- PRAX 299.7K
- GES 914.4K
- Earning Date
- PRAX 08-12-2025
- GES 08-27-2025
- Dividend Yield
- PRAX N/A
- GES 9.29%
- EPS Growth
- PRAX N/A
- GES N/A
- EPS
- PRAX N/A
- GES 0.10
- Revenue
- PRAX $8,122,000.00
- GES $3,051,131,000.00
- Revenue This Year
- PRAX N/A
- GES $7.34
- Revenue Next Year
- PRAX $6,358.50
- GES $3.20
- P/E Ratio
- PRAX N/A
- GES $133.63
- Revenue Growth
- PRAX 270.02
- GES 9.02
- 52 Week Low
- PRAX $26.70
- GES $8.48
- 52 Week High
- PRAX $91.83
- GES $24.64
- Technical
- Relative Strength Index (RSI)
- PRAX 63.87
- GES 65.19
- Support Level
- PRAX $40.93
- GES $11.80
- Resistance Level
- PRAX $44.40
- GES $12.16
- Average True Range (ATR)
- PRAX 2.26
- GES 0.47
- MACD
- PRAX -0.08
- GES 0.08
- Stochastic Oscillator
- PRAX 95.12
- GES 93.69
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.